… in hematological disorders, remaining challenges, and future perspectives of iPSCs in …
cellular reprogramming in basic research and potential applications in hematological disorders…

… to kill the very last leukemic cell despite longterm disease-free … stem cell transplantations
in patients with hematological ma… if all of the leukemic cells were able to initiate a relapse [5]. …

… research and public fascination with promises of stem cell-based therapies, … stem cells in
therapy for non-hematological disorders. To get an overview of clinical trials with UCB stem cells…

… A total of 489 patients with non-malignant hematological disorders were included in this
study; 344 males and 135 females (M/F ratio 2.5:1), including 273 SAA patients; 152 BTM …

… hematopoietic stem cell transplantation, which shows great potential in treatment of hematologic
… characteristics and mechanism of UC-MSCs in treatment of hematological diseases. …

… to originate from hematopoietic stem or progenitor cells, not only adopt … for hematological
malignancies is hematopoietic stem cell … The review gives an insight of different hematological …

… ature have been studying stem cell application in terms of clinical practice, stem cell-based …
stem cells, neural stem cells, epithelial stem cells, and mesenchymal stem cells10. The later …

… have been described in hematological malignancies, as well as in rare genetic disorders,
diseases that are amenable to allogeneic hematopoietic stem cell transplantation (HSCT), and …

… hematological disorders. In particular, patients undergoing allogeneic hematopoietic stem-cell …
and CNS involvement of the underlying hematological disorder may mimic symptoms of a …

… tool for hematologic disorders and highlight recent hereditary and acquired hematologic
disease … and potential therapeutic candidates for hematologic disorders, with or without further …